English | Español
Amanda Rupp | Jun 3, 2016

BioMarin withdraws Kyndrisa's marketing authorization for Europe
Amanda Rupp | Jun 2, 2016

Imbruvica gains approval for treating chronic lymphocytic leukemia
Amanda Rupp | Jun 1, 2016

NCHC applauds hospital readmissions policy changes
Amanda Rupp | Jun 1, 2016

CHMP gives positive opinion of Zepatier tablet
Amanda Rupp | Jun 1, 2016

First buprenorphine implant treatment for opioid dependence earns FDA approval
Amanda Rupp | May 26, 2016

Hospital bill passes House Ways and Means Committee
Amanda Rupp | May 26, 2016

AMA celebrates new nutrition labels highlighting sugar amounts
Amanda Rupp | May 25, 2016

HHS launches challenge for improved medical bill

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments